| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.265 | 7.853 | - | - | - | - | - | - | - | - |
| Total Income - EUR | 8.400 | 7.985 | - | - | - | - | - | - | - | - |
| Total Expenses - EUR | 12.169 | 23.379 | - | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -3.769 | -15.394 | - | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -4.031 | -15.558 | - | - | - | - | - | - | - | - |
| Employees | 1 | 1 | - | - | - | - | - | - | - | - |
Check the financial reports for the company - Pharmax S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 44.903 | 35.163 | - | - | - | - | - | - | - | - |
| Current Assets | 33.909 | 31.462 | - | - | - | - | - | - | - | - |
| Inventories | 28.235 | 31.003 | - | - | - | - | - | - | - | - |
| Receivables | 908 | 0 | - | - | - | - | - | - | - | - |
| Cash | 4.766 | 459 | - | - | - | - | - | - | - | - |
| Shareholders Funds | 70.880 | 54.599 | - | - | - | - | - | - | - | - |
| Social Capital | 67 | 67 | - | - | - | - | - | - | - | - |
| Debts | 8.005 | 12.026 | - | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | - | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharmax S.r.l.